NCT00303368View on ClinicalTrials.gov

Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia

CompletedOBSERVATIONAL
Enrollment

395

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2016

Conditions
Neurofibromatosis Type 1Tibial Dysplasia
Trial Locations (1)

84103

Shriners Hospitals for Children, Intermountain Hospital, Salt Lake City

All Listed Sponsors
collaborator

University of Utah

OTHER

lead

Shriners Hospitals for Children

OTHER

NCT00303368 - Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia | Biotech Hunter | Biotech Hunter